Get started
Live feed
·
PRReleasevia Quantisnow
Disc Medicine Inc. logo

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)

ByQuantisnow·Wall Street's wire, on your screen.
IRONDisc Medicine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRON (Disc Medicine Inc.) and more on Quantisnow.